Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,385 | 3,255 | 1,738 | 1,143 | 880 |
| Marketable Securities | 41 | 32 | 32 | 54 | 54 |
| Receivables | 358 | 390 | 212 | 82 | 135 |
| TOTAL | $2,784 | $3,677 | $1,982 | $1,279 | $1,069 |
| Non-Current Assets | |||||
| PPE Net | 445 | 394 | 158 | 96 | 100 |
| Other Non-Current Assets | 63 | 71 | 30 | 36 | 42 |
| TOTAL | $508 | $465 | $188 | $132 | $142 |
| Total Assets | $3,292 | $4,142 | $2,170 | $1,411 | $1,211 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 371 | 102 | 317 | 354 | 153 |
| Accrued Expenses | 173 | 231 | 299 | 269 | 284 |
| Other current liabilities | 2 | 29 | 1,292 | N/A | N/A |
| TOTAL | $546 | $362 | $1,908 | $623 | $437 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 171 | 149 | 73 | 67 | 84 |
| TOTAL | $171 | $149 | $73 | $67 | $84 |
| Total Liabilities | $717 | $511 | $1,981 | $690 | $521 |
| Shareholders' Equity | |||||
| Retained earnings | -16,304 | -14,979 | -14,057 | -13,320 | -12,163 |
| Other shareholders' equity | 2,051 | 2,113 | 947 | 1,885 | 1,575 |
| TOTAL | $2,575 | $3,631 | $189 | $721 | $690 |
| Total Liabilities And Equity | $3,292 | $4,142 | $2,170 | $1,411 | $1,211 |